የካንሰር ፋውንዴሽን መከላከል የሜዲኬር መልቲ-ካንሰር ቅድመ ምርመራ የማጣሪያ ሽፋን ህግን ማስተዋወቅ ያደንቃል

ለፈጣን መልቀቅ 

December 3, 2020

Media Contact
ሊዛ ቤሪ ኤድዋርድስ
Lisa.Berry@preventcancer.org

WASHINGTON, D.C. – The Prevent Cancer Foundation^® applauds congressional leaders for the introduction of the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021, which will usher in a new era in our pursuit to prevent cancer. H.R. 8845 sponsored by U.S. Reps. Terri Sewell (AL-07), Jodey Arrington (TX-19), Raul Ruiz (CA-36), and Richard Hudson (NC-08) will provide seniors with access to emerging innovations that may enable the detection of multiple cancers from a simple blood sample.

“Finding cancer early is one of the surest ways to beat it,” said Carolyn Aldigé, Founder and CEO of the Prevent Cancer Foundation. “At Prevent Cancer Foundation, we’re focused on expanding access to routine and recommended screenings and ensuring patients and their health care providers benefit from the latest innovations to detect cancer earlier. Multi-cancer early detection tests are a medical advance that can dramatically increase our cancer screening capabilities.”

Current screening for breast, cervical, colorectal, lung and prostate cancers is vital in reducing the burden of cancer. Finding cancer early, before it has spread to other parts of the body, increases the likelihood treatment will be successful, lowers the cost of treatment and improves quality of life for patients and their caregivers. But today we have recommended screenings for only a few of the more than 200 cancers, leaving most cancers undetected until symptoms appear in later stages.

The ability to expand early detection may be imminent. Scientists have developed new screening technologies that are currently in clinical testing by multiple companies and are showing positive results. With a single blood sample, these tests can identify multiple cancers in early stages. Recognizing the public health impact of this innovation, the U.S. Food and Drug Administration has granted these tests breakthrough device designations.

“Once multi-cancer early detection tests are approved by the FDA, we must make sure Medicare coverage of these tests is in place so patients can access and afford them,” said Aldigé. “It is encouraging to see a bipartisan group of forward-thinking members of Congress leading on this issue. Cancer affects so many Americans and multi-cancer screening could make a real and lasting impact on the group at greatest risk of cancer—our seniors.”

ይህ ያለፈው ዓመት የኮሮና ቫይረስ ወረርሽኝ በተከሰተበት ወቅት ለካንሰር ምርመራ በጣም ከባድ ነበር። በካንሰር ምርመራ ላይ አዳዲስ እድገቶችን ለማግኘት ከመምከር በተጨማሪ፣ የ Prevent Cancer Foundation አሜሪካውያን ያመለጡ ወይም የዘገዩ ምርመራዎችን እንዲያገኙ በማረጋገጥ ላይ ያተኮረ ነው። ወደ መጽሐፍት ተመለስ. የእርስዎን መደበኛ የካንሰር ምርመራዎች ደህንነቱ በተጠበቀ ሁኔታ ለማከናወን ስለ ሃብቶቹ እና መሳሪያዎች የበለጠ ይወቁ።

ስለ ካንሰር መከላከል ፋውንዴሽን

የካንሰር መከላከያ ፋውንዴሽን^® የዩናይትድ ስቴትስ ብቸኛው ለትርፍ ያልተቋቋመ ድርጅት ካንሰርን በመከላከል እና አስቀድሞ በመለየት ህይወቶችን በማዳን ላይ ብቻ ያተኮረ 35 ዓመታትን እያከበረ ነው። በምርምር፣ ትምህርት፣ ተደራሽነት እና ድጋፍ፣ ስፍር ቁጥር የሌላቸው ሰዎች የካንሰር ምርመራ እንዳይደረግባቸው ወይም ካንሰርን በተሳካ ሁኔታ እንዲታከሙ ቀድመን እንዲያውቁ ረድተናል።

ፋውንዴሽኑ በ2035 የካንሰር ሞትን በ401ቲፒ3ቲ በመቀነስ ላይ ያለውን ፈተና ለመቋቋም $20 ሚሊዮን ለፈጠራ ቴክኖሎጂዎች በማፍሰስ ካንሰርን ቀድመን በመለየት የብዝሃ ካንሰር ምርመራን ለማስፋፋት $10 ሚሊዮን የካንሰር ምርመራና ክትባቱን ለማስፋፋት ቁርጠኛ ነው። በህክምና ያልተጠበቁ ማህበረሰቦችን ማግኘት፣ እና $10 ሚሊዮን ስለማጣሪያ እና የክትባት አማራጮች ህዝቡን ለማስተማር።

ለበለጠ መረጃ፣ እባክዎን ይጎብኙ www.preventcancer.org.